Governor Greg Abbott made bail reform one of his top priorities this legislative session. But the proposals he’s backing ...

Two claims in a whistleblower suit alleging that Abbott Laboratories Inc. and others improperly billed the government for ...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products ...

Abbott Laboratories (ABT) gains 1.4% as a judge rules in its favor in a baby formula trial. Learn about the case and ...

April 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving pulsed field ...

Along the way, the AI companies behind them treat our shared culture like an inexhaustible resource to be strip-mined, with little thought for the consequences. But human creativity isn't the ...

First point of contact Assists all employees in completing new hire paperwork (i.e., I-9, tax forms) Answers main phone line Answers basic HR questions ...

Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the June 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABT ...

The streak dates back to its years as part of Abbott Laboratories. AbbVie began trading in 2012 following its spinoff from Abbott. At the current share price, the dividend yields a solid 3.7%.

Abbott Laboratories (NYSE:ABT – Get Free Report) had its target price hoisted by research analysts at Raymond James from $132.00 to $142.00 in a research note issued on Thursday,Benzinga reports.

Shares of ABT stock opened at $131.00 on Thursday. The company has a quick ratio of 1.14, a current ratio of 1.60 and a debt-to-equity ratio of 0.32. Abbott Laboratories has a 52 week low of $99. ...